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This issue of Pediatric Annals presents three case vignettes in which the patient or patients suffer from an unusual systemic cause for their skin fi ndings. As well, two short reviews of environmental causes for skin irritation are provided to alert the practicing healthcare professional to increasingly common but often overlooked chemical irritants in children.
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One Disease, Multiple Manifestations
CASE 1
A 5-year-old Hispanic girl was evaluated for recurrent torticollis over a period of 1 year, which was interfering with regular activities. Cervical spine studies were normal. Ibuprofen, rest, and parental reassurance were given. Two months later, she was evaluated for persistence of torticollis. On exam, she was apprehensive, her head was tilted to the left, and she refused to move her neck. The left posterior-lateral neck region was tender on palpation. The remaining physical and neurological exam was unremarkable. Magnetic resonance imaging (MRI) showed a destructive process of the left portion of the body of C2 extending into the left lamina and dens, not involving the spinal cord or vertebral artery (see Figure 1 ). An osteomyelitic process with an infl ammatory phlegmon was considered. Biopsy revealed a histiocytic infi ltrate with S100 and CD1a expression.
CASE 2
A 22-month-old male received oral antibiotics for an infl ammatory process of the lower right hemi-mandible. A month later, the swelling persisted. A 3.5 x 10 x 1 cm ulcerative lesion destroying the right posterior alveolar ridge of mandible with a necrotic base and foul smelling discharge was noted. Within an anterior gingival tissue prominence, the upper portion of a tooth was seen protruding (see Figure 2 , page 93). Several enlarged, non-tender fi rm lymph nodes measuring up to 1.5 cm were noted on the posterior triangle of the neck bilaterally. "Floating teeth" were seen by Panorex exam. Computerized tomography (CT) scan showed a destructive lesion in the body of the mandible. Biopsy revealed an infi ltrate of histiocytes with S100 and CD1a expression.
CASE 3
A 14-month-old girl presented with bronchiolitis, anemia, hypoalbumemia, mild thrombocytopenia, and hepatosplenomegaly. The week prior to admission, she had fevers up to 103° F with a clear nasal drainage and right inguinal lymphadenopathy. EBV titers were elevated. Minimal ascites and retroperitoneal adenopathy were noted by CT scan.
Past medical history was signifi cant for surgical repair of transposition of the great vessels. Working diagnosis included EBV-related hemophagocytic syndrome. A bone marrow biopsy was normal. Her lymphadenopathy improved, but hepatosplenomegaly persisted. Multiple blood transfusions were required. Platelets decreased to the 40,000/mm 3 to 60,000/mm 3 level. A skeletal survey showed lytic lesions adjacent to the left orbit and in the left iliac wing. CT-guided biopsy of the left iliac wing lytic lesion showed a histiocytic infi ltrate S100 and CD1a positive (see Figure 3) .
CASE 4
A 1-year-old boy presented with multiple scaly, maculoerythematous scalp lesions measuring up to 1 cm in diameter, which had been treated for a month as seborrheic dermatitis. He was appropriately developed for age, and no other abnormal fi ndings were present on physical and radiological exam. Biopsy revealed S100 and CD1a positive histiocytic infi ltrate (see Figure 4 , page 94).
DISCUSSION
Langerhan's cell histiocytosis (LCH) consists of a group of syndromes characterized by an abnormal increase in the number of dendritic antigen presenting cells involving single or multiple organs.
1,2 Although the etiology and Although the etiology and pathogenesis of LCH are still unknown, it is suggested it may be a reactive disease caused by abnormal immune regulation.
pathogenesis of LCH are still unknown, it is suggested it may be a reactive disease caused by abnormal immune regulation. [1] [2] [3] Approximately 1,200 new cases per year are reported in the United States, with an incidence of 1.08 per 200,000 per year in children younger than 15 years of age. 4 It most commonly affects children between 1 and 15 years, 4, 5 while neonatal presentation is rare. Being so uncommon, general pediatricians usually do not consider histiocytosis in their evaluation.
The clinical manifestations of LCH depend on the site of the lesions and organs and systems involved. Single-system or unifocal LCH presents with solitary or few indolent and chronic lesions of bone or other organs. Multi-system or multifocal LCH can present as an acute, fulminant, disseminated disease (Letterer-Siwe disease). The clinical triad of multifocal bone lesions, diabetes insipidus (DI), and proptosis (Hand-Schüller-Christian disease) is rarely noted. 4, 5 The LCH infi ltrate may involve bones, skin, teeth, gingival tissues, ears, endocrine organs, lungs, liver, spleen, lymph nodes, and bone marrow, interfering with normal function. In the initial evaluation, a skeletal survey will show bone involvement in 78% of cases. Lesions may affect the skull (49%), pelvic bone (23%), femur (17%), orbit (11%), and ribs (8%). [4] [5] [6] Spinal involvement may be asymptomatic or painful and can present as torticollis or back pain. The thoracic vertebrae are most commonly involved, followed by the cervical and lumbar. Vertebral body collapse ("vertebra plana") and neurological defi cits may occur. 7, 8 Mastoid process involvement can mimic mastoiditis, while that of the ossicles may result in deafness. 5 Gingival and soft tissue swelling, fractures, or pain characterize mandibular involvement with "fl oating teeth" noted in a Panorex exam. 9 Orbital involvement may cause proptosis. Unfavorable prognostic factors include age of < 2 years, the presence of anemia, liver and spleen involvement, and respiratory failure. Bone marrow dysfunction in LCH is associated with hepatosplenomegaly and pancytopenia and has a very poor prognosis. An affi nity for bile duct involvement can lead to sclerosing cholangitis and, eventually, biliary cirrhosis. 1, 10 Cutaneous lesions may rarely be the sole manifestation and predominantly affect male infants younger than 1 year.
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Lesions are scaly, erythematous, seborrhea-like, with or without superfi cial ulceration and weeping eczema. Spontaneous regression occurs frequently (Hashimoto-Pritzker variant).
DIAGNOSIS
99 Technetium MDP bone scan is useful for evaluation of age and activity of lesions. Still, lesions are not visualized by these techniques in 16% to 19% (by scan) to 29% (by plain fi lm) of cases.
Positron emission tomography (PET)-CT imaging has detected lesions missed by these methods. Patients with multiple lesions are at an increased risk of recurrence (18%) but especially so if skull lesions are present (39%). 12 Cutaneous lesions need assessment of systemic involvement and skin biopsy are needed to differentiate it from common dermatological disorders. A defi nitive diagnosis is made by the typical histological features of Langerhan's cells and immunophenotype with expression of S-100, CD1a, and langerin (CD207).
2 Electronic microscopy is now seldom required to identify Bierbeck granules.
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TREATMENT
Treatment varies depending on extent of involvement. Curettage, intralesional steroids, or radiotherapy may suffi ce for solitary bone lesions. Patients with multiple system involvement are considered "high risk" if the liver, spleen, lungs, or hematopoietic system are involved. Prednisone, vinblastin, and intermediate dose IV methotrexate are given initially. 6-MP, prednisone, vinblastine, and oral methotrexate may then follow for up to a year. Patients with multiple system involvement in the "low-risk" category The clinical manifestations of LCH depend on the site of the lesions and organs and systems involved.
may receive similar initial therapy with prednisone and vinblastine administered during continuation therapy for up to a year. Guidelines for therapy are delineated in the LCH-III protocol, to which the reader is directed as an invaluable reference. 13 Novel agents such as 2-CDa with high dose Ara-C, tumor necrosis factor inhibitor, and pamidroate have been tried with varying success. 6 Treatment of vertebral lesions by Brown et al included external support of the involved vertebra initially by bracing followed by thoracolumbar sacral orthosis, soft tissue collar, or Jewett brace for a variable time period depending on clinical evolution. Surgery, steroids, chemotherapy, and radiotherapy were also utilized in some patients. 14 Dermal lesions may benefi t from local or systemic steroids. Topical tacrolimus, 20% nitrogen mustard, and psoralens with ultraviolet radiation have been tried with limited success. 15 Endocrine evaluation is strongly encouraged 6 for patients with polyuria (DI) and may be controlled with intranasal DDAVP spray applications.
All four of our patients responded to treatment with resolution of their lesions, normalization of blood counts, and overall clinical improvement. Our patient with skin involvement required additional treatments, including topical tacrolimus, topical nitrogen mustard applications, oral thalidomide, and oral methotrexate.
CONCLUSIONS
Although rare, LCH can present the pediatrician with a challenging diagnostic and treatment dilemma, mimicking various disease processes. Clinical fi ndings can be insidious or overt and may range from a single isolated skin lesion to varying involvement and functional compromise of multiple organ systems. Early diagnosis, treatment, and long-term follow-up care by a multidisciplinary team are critical for the long-term prognosis.
